{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:20:04Z","timestamp":1792624804511,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["theocularsurfacejournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jtos.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T12:09:30Z","timestamp":1520078970000},"page":"289-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye"],"prefix":"10.1016","volume":"16","author":[{"given":"Aaron B.C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak J.","family":"Prime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-5319","authenticated-orcid":false,"given":"Jennifer P.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","article-title":"Glaucoma therapy and ocular surface disease: current literature and recommendations","volume":"24","author":"Anwar","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib2","article-title":"How ocular surface disease impacts the glaucoma treatment outcome","author":"Kastelan","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtos.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/02713683.2011.562340","article-title":"Ocular surface disease in patients with ocular hypertension and glaucoma","volume":"36","author":"Stewart","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.jtos.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00417-012-1943-6","article-title":"Effects of long-term topical anti-glaucoma medications on meibomian glands","volume":"250","author":"Arita","year":"2012","journal-title":"Graefes Arch Clin Exp"},{"key":"10.1016\/j.jtos.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ICO.0b013e31823f8e7d","article-title":"Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands","volume":"31","author":"Arita","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/IJG.0000000000000495","article-title":"The association of chronic topical prostaglandin analog use with meibomian gland dysfunction","volume":"25","author":"Mocan","year":"2016","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.jtos.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/ICO.0000000000000838","article-title":"Meibomian gland dysfunction in patients receiving long-term glaucoma medications","volume":"35","author":"Uzunosmanoglu","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-4835(03)00203-3","article-title":"The lipid layer of tears: dependent on meibomian gland function","volume":"78","author":"McCulley","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006324-199701000-00014","article-title":"Importance of the lipid layer in human tear film stability and evaporation","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/eye.2013.144","article-title":"Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity","volume":"27","author":"Lee","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1097\/OPX.0000000000000601","article-title":"Comparison of self-applied heat therapy for meibomian gland dysfunction","volume":"92","author":"Wang","year":"2015","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/978-1-4615-5359-5_121","article-title":"Use of the Tearscope Plus and attachments in the routine examination of the marginal dry eye contact lens patient","volume":"438","author":"Guillon","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtos.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jtos.2016.03.002","article-title":"Exploring the predisposition of the asian eye to development of dry eye","volume":"14","author":"Craig","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.ICL.0000140910.03095.FA","article-title":"Lid wiper epitheliopathy and dry eye symptoms","volume":"31","author":"Korb","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","article-title":"Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location","volume":"27","author":"Korb","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clae.2012.10.074","article-title":"Comparison of subjective grading and objective assessment in meibography","volume":"36","author":"Pult","year":"2013","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2018.03.002_bib27","first-page":"478","article-title":"Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye","volume":"5","author":"Li","year":"2012","journal-title":"Int J Opthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/ICO.0b013e31823f8cb6","article-title":"Tear film osmolarity in patients treated for glaucoma or ocular hypertension","volume":"31","author":"Labbe","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","article-title":"Ocular surface alteration after long-term treatment with an antiglaucomatous drug","volume":"99","author":"Herreras","year":"1992","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","article-title":"Adverse effects of topical antiglaucoma drugs on the ocular surface","volume":"28","author":"Arici","year":"2000","journal-title":"Clin Exp Opthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00061198-200312000-00007","article-title":"Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy","volume":"12","author":"Inoue","year":"2003","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.jtos.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/IJG.0000000000000227","article-title":"Time course of prostaglandin analog-related conjunctival hyperemia and the effect of a nonsteroidal anti-inflammatory ophthalmic solution","volume":"25","author":"Sakata","year":"2016","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.jtos.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ajo.2014.03.002","article-title":"New testing options for diagnosing and grading dry eye disease","volume":"157","author":"Foulks","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012417303117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012417303117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T16:42:08Z","timestamp":1538152928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012417303117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1542012417303117"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2018.03.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}